Search results for "PIDE"

showing 10 items of 6055 documents

Epidemiologic Analysis of Asteroid Hyalosis and Associations: The Gutenberg Health Study

2021

AdultMalemedicine.medical_specialtyAsteroid hyalosisEye Diseasesbusiness.industryIncidenceVision DisordersMEDLINEMiddle AgedDermatologyVitreous BodyEpidemiologic StudiesOphthalmology/dk/atira/pure/subjectarea/asjc/2700/2731GermanyPrevalencemedicineHumansFemalebusinessAgedOphthalmology
researchProduct

Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta-analysis

2013

© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

AdultMalemedicine.medical_specialtyBipolar DisorderBipolar disorderTrail Making TestReviewNeuropsychological TestsVerbal learning03 medical and health sciencesMental Processes0302 clinical medicineRisk FactorsmedicineMemory spanHumansMental CompetencyAffective SymptomsBipolar disorderAge of OnsetPsychiatryPsychiatric Status Rating ScalesPsychotropic DrugsNeuropsychologyConfounding Factors EpidemiologicMiddle Agedmedicine.disease030227 psychiatryAffectPsychiatry and Mental healthMoodCognitive impairmentSchizophreniaNeuropsychological testsFemaleVerbal memoryCognition DisordersPsychology030217 neurology & neurosurgeryClinical psychology
researchProduct

Bipolar I and Bipolar II Disorder: Cognition and Emotion Processing

2006

Background. Cognitive impairment may be part of the endophenotype of bipolar disorder (BP), but little is known about patterns and severity of impairment in BP subgroups and their relation to depression. The same applies to deficits in emotion processing known to be present in BP.Method. To explore the relationship between depression and impairment in cognition and emotion processing and the differences between BP subgroups, we assessed 36 (25 BP I and 11 BP II) patients using a cognitive battery and a facial emotion recognition task.Results. BP patients were impaired compared to published norms on memory, naming and executive measures (Binomial Single Proportion tests, p<0·05). Cognitiv…

AdultMalemedicine.medical_specialtyBipolar Disordermedicine.medical_treatmentNeuropsychological TestsSeverity of Illness IndexBipolar II disorderElectroconvulsive therapymedicineHumansEffects of sleep deprivation on cognitive performanceBipolar disorderPsychiatryApplied PsychologySettore M-PSI/02 - Psicobiologia E Psicologia FisiologicaCognitive disorderCognitionmedicine.diseaseDiagnostic and Statistical Manual of Mental DisordersPsychiatry and Mental healthAffectEndophenotypeFemaleAdult Affect* Bipolar Disorder/diagnosis* Bipolar Disorder/epidemiology* Cognition Disorders/diagnosis Cognition Disorders/epidemiology Diagnostic and Statistical Manual of Mental Disorders Female Humans Male Neuropsychological Tests Severity of Illness Indexmedicine.symptomPsychologyCognition DisordersManiaClinical psychology
researchProduct

Epidemiological survey of 214 families with bladder exstrophy-epispadias complex.

2007

We sought to identify causative nongenetic and genetic risk factors for the bladder exstrophy-epispadias complex.A total of 237 families with the bladder exstrophy-epispadias complex were invited to participate in the study, and information was obtained from 214 families, mainly from European countries.Two families showed familial occurrence. Male predominance was found among all subgroups comprising epispadias, classic bladder exstrophy and cloacal exstrophy, with male-to-female ratios of 1.4:1, 2.8:1 and 2.0:1, respectively (p = 0.001). No association with parental age, maternal reproductive history or periconceptional maternal exposure to alcohol, drugs, chemical noxae, radiation or infe…

AdultMalemedicine.medical_specialtyBladder exstrophy epispadias complexEpispadiasUrologymedicine.medical_treatmentEpispadiasIntracytoplasmic sperm injectionArticleRisk FactorsEpidemiologymedicineHumansGenetic Predisposition to DiseaseGynecologyNeural tube defectObstetricsbusiness.industryBladder ExstrophyInfant NewbornSyndromeCloacal exstrophymedicine.diseaseBladder exstrophyEuropeFemaleCloacabusinessThe Journal of urology
researchProduct

Five-year prospective study on cardiovascular events, in patients with erectile dysfunction and hypotestosterone.

2017

Objective: Testosterone levels play a role in cardiac and vascular pathology. In the present study we investigated the prognostic significance of this hormone for cardiovascular outcome, in a 5-year follow-up. Materials and methods: Our cohort included 802 adult subjects, from 40 to 80 years. Patients were excluded if they had a past history of peripheral or coronary artery disease, and revascularization. A blood sample was drawn to valuate testosterone level, and we considered normal testosterone levels 300 ng/dl. FMD (flow mediated dilatation) of the brachial artery was assessed by measuring the increase of the brachial artery diameter during reactive hyperemia after transient forearm isc…

AdultMalemedicine.medical_specialtyBrachial ArteryUrologyCardiovascular event030204 cardiovascular system & hematologylcsh:RC870-923Settore MED/24 - UrologiaCardiovascular eventsCoronary artery diseaseCohort Studies03 medical and health sciences0302 clinical medicineErectile DysfunctionRisk Factorsmedicine.arteryInternal medicineSurveys and QuestionnairesmedicineHumansTestosteroneObesityProspective StudiesBrachial arteryProspective cohort studyStrokeReactive hyperemiaAgedDyslipidemiasAged 80 and overbusiness.industryPrevention030208 emergency & critical care medicineTestosterone (patch)Middle Agedlcsh:Diseases of the genitourinary system. Urologymedicine.diseasePrognosisSettore MED/11 - Malattie Dell'Apparato CardiovascolareErectile dysfunctionLogistic ModelsCardiovascular DiseasesCardiologybusinessDyslipidemiaFollow-Up StudiesArchivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica
researchProduct

Patients requiring interruption of long-term oral anticoagulant therapy: the use of fixed sub-therapeutic doses of low-molecular weight heparin.

2009

Introduction: We tested the efficacy and safety of fixed doses of Low-Molecular Weight Heparin (LMWH) in patients requiring interruption of Vitamin-k Antagonist (VKA) because of invasive procedures Methodology: Pre-operatively, patients discontinued VKA 5 +/- 1days; in those at low-risk for thrombosis, LMWH was given at a prophylactic dosage of 3.800 U.I. (nadroparin) or 4.000 U.I. (enoxaparin) anti-FXa once daily the night before the procedure. In patients at high-risk for thrombosis, LMWH was started early after VKA cessation and given at fixed sub-therapeutic doses (3.800 or 4.000 UI anti-FXa twice daily) until surgery. Post-operatively, LMWH was reinitiated 12 hours after procedure whil…

AdultMalemedicine.medical_specialtyBridging low molecular weight heparinTime FactorsVitamin Kmedicine.drug_classLow molecular weight heparinAdministration OralPostoperative HemorrhageRisk AssessmentDrug Administration ScheduleSettore MED/15 - Malattie Del SangueRisk FactorsThromboembolismmedicineHumansProspective StudiesEnoxaparinProspective cohort studyAgedAged 80 and overbusiness.industryIncidence (epidemiology)WarfarinAnticoagulantsNadroparinHematologyHeparinHeparin Low-Molecular-WeightMiddle Agedmedicine.diseaseThrombosisConfidence intervalSurgeryLow Molecular Weight Heparin Fixed doses Chronic oral anticoagulation perioperative bridgingAnesthesiaSurgical Procedures OperativeNadroparinFeasibility StudiesFemaleWarfarinbusinessmedicine.drugFactor Xa Inhibitors
researchProduct

Short-and long-term outcome after PTCA in patients with stable and unstable angina

1990

Acute results and follow-up data over a period of 36 months after attempted PTCA in 406 patients with stable angina and 202 patients with unstable angina are reported. The rate of acute complications (death, myocardial infarction and bypass grafting (CABG) amounted to 1.5% in stable and 6.4% in unstable patients (P less than 0.005). Within the first week after PTCA a significantly lower percentage (1.7% vs 10.4%) of cardiac events (death, myocardial infarction, CABG and repeat PTCA) was observed in the stable group (P less than 0.001). During a 12-month follow-up period, another 16.3% of the patients in the stable group and 30.7% of unstable patients suffered a new cardiac event (P less tha…

AdultMalemedicine.medical_specialtyBypass graftingMyocardial InfarctionAsymptomaticAngina PectorisPostoperative ComplicationsInternal medicinemedicineHumansIn patientAngina Unstablecardiovascular diseasesMyocardial infarctionAngioplasty Balloon CoronaryCoronary Artery BypassMedical treatmentUnstable anginabusiness.industryIncidence (epidemiology)Middle AgedPrognosismedicine.diseaseQuality of LifeCardiologyFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessEarly phaseFollow-Up StudiesEuropean Heart Journal
researchProduct

Competitive interaction between chronic obstructive pulmonary disease and CHA2DS2-VASc score in predicting incident atrial fibrillation

2018

Background: Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality, and an emerging risk factor for atrial fibrillation (AF). CHADS2 and CHA2DS2-VASc scores are significantly associated with incident AF independently of other risk factors. The aim of this study was to demonstrate a possible interaction between COPD and CHA2DS2-VASc in predicting incident AF. Methods: This observational prospective cohort study included 4322 Caucasians with cardiovascular risk factors, stratified by CHA2DS2-VASc score (> 2 vs < 2) and presence/absence of COPD. To detect AF appearance, patients underwent, every 6 months, physical examination, standard 12‑lead electrocardiog…

AdultMalemedicine.medical_specialtyCHA2DS2-VASc scorePulmonary diseasePredictive Value of Test030204 cardiovascular system & hematologySeverity of Illness IndexFollow-Up Studie03 medical and health sciencesPulmonary Disease Chronic Obstructive0302 clinical medicineInternal medicinemedicineCompetitive interaction030212 general & internal medicineProspective cohort studyAgedCOPDbusiness.industryProportional hazards modelIncidence (epidemiology)Chronic obstructive pulmonary diseaseIncidenceAtrial fibrillationMiddle Agedmedicine.diseaseCardiovascular riskAtrial fibrillationProspective Studieatrial fibrillation; cha(2)ds(2)-vasc score; cardiovascular risk; chronic obstructive pulmonary diseaseCHA2DS2–VASc scoreCardiologyFemaleCohort StudiebusinessCardiology and Cardiovascular MedicineHuman
researchProduct

Treating homozygous familial hypercholesterolemia in a real-world setting: Experiences with lomitapide

2015

Homozygous familial hypercholesterolaemia (HoFH) is a rare genetic disease characterised by markedly elevated plasma levels of low-density lipoprotein-cholesterol (LDL-C). Lomitapide is a microsomal triglyceride transfer protein (MTP) inhibitor approved as an adjunct to other lipid-lowering therapies (LLTs), with or without lipoprotein apheresis (LA), for the treatment of adult HoFH. Diet with &lt;20% calories from fat is required. Due to a varying genetic and phenotypic profile of patients with HoFH, individual patients may respond to therapy differently; therefore examining individual cases in a &apos;real-world&apos; setting provides valuable information on the effective day-to-day manag…

AdultMalemedicine.medical_specialtyCalorieSettore MED/09 - Medicina InternaEndocrinology Diabetes and MetabolismCase studyFamilial hypercholesterolemiaHomozygous familial hypercholesterolemiaFamilial hypercholesterolemiaDiseaseCompound heterozygosityHyperlipoproteinemia Type IIchemistry.chemical_compoundInternal medicineCase study; Familial hypercholesterolemia; Homozygous familial hypercholesterolemia; Lomitapide; Treatment; Cardiology and Cardiovascular Medicine; Endocrinology Diabetes and Metabolism; Internal Medicine; Nutrition and DieteticsInternal MedicinemedicineHumansAdverse effectNutrition and Dieteticsbusiness.industryAnticholesteremic AgentsHomozygoteCholesterol LDLMiddle Agedmedicine.diseaseLomitapideLomitapideTreatmentClinical trialEndocrinologychemistryBenzimidazolesFemaleSteatosisCardiology and Cardiovascular Medicinebusiness
researchProduct

A pioneering epidemiological study investigating the incidence of squamous cell carcinoma of tongue in a Portuguese population

2012

Objective: The purpose of this study was to investigate the incidence of squamous cell carcinoma (SCC) of the anterior two thirds of the tongue in a population living in central and southern Portugal, all treated at Portuguese Institute of Oncology of Lisbon, Francisco Gentil (IPOLFG). Study Design: This study was a retrospective review of all patients who had a histopathological diagnosis of SCC of the anterior two thirds of the tongue and had been treated in the Head and Neck Surgery Unit at the IPOLFG (Lisbon, Portugal), between 1st January 2001 and 31st December 2009. The risk factors evaluated were: gender; age; alcohol consumption; tobacco use; prosthesis use and the carcinoma site. R…

AdultMalemedicine.medical_specialtyCancer cellsPopulationYoung AdultTongueEpidemiologyCarcinomamedicineHumansTongue NeoplasmeducationGeneral DentistryAgedRetrospective StudiesAged 80 and overMoutheducation.field_of_studyOral Medicine and PathologyPortugalPortuguesebusiness.industryIncidenceBocaIncidence (epidemiology)Retrospective cohort studyMiddle Aged:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseTongue NeoplasmsPortuguesosSurgerymedicine.anatomical_structureOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASCarcinoma Squamous CellEtiologyResearch-ArticleFemaleCèl·lules cancerosesSurgerybusinessDemographyMedicina Oral Patología Oral y Cirugia Bucal
researchProduct